Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Opinion
APAC / Aligning Combination Product Regulations: A Distant Dream?
Writing in the April edition of DIA’s Global Forum magazine, Dhiraj Behl, Janine Jamieson, and Harikesh Kalonia highlight some of the regulatory challenges for drug-device combination products in APAC, including the lack…
Latvia / Striving to Catch Up to its Neighbours on Innovation Access
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
In Conversation
Exclusive: Thomas Cueni on 50 years of global progress
The past 5 decades have seen monumental strides in healthcare; from the discovery that aspirin prevents blood clotting to the eradication of smallpox. In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reflects on 50 years of innovation from the associations housed under their umbrella and looks towards the biggest challenges healthcare is…
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
LatAm & Caribbean / Importance of Reliance to Support Strengthening Regulatory Systems
Writing in the April edition of DIA’s Global Forum magazine, Maria Cristina Mota Pina of Abbvie on behalf of…
Germany: The Essential Requirements on Trading Medical Cannabis under the 1961…
Dentons Germany’s Peter Homberg outlines the key requirements that companies need to fulfil in order to…
USA / Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Latvia / Striving to Catch Up to its Neighbours on Innovation Access
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
APAC / Aligning Combination Product Regulations: A Distant Dream?
Writing in the April edition of DIA’s Global Forum magazine, Dhiraj Behl, Janine Jamieson, and Harikesh Kalonia…
Europe / After Brexit: Focus on the New Pharmaceutical Strategy for Europe
Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the…
China / Public Insurance Coverage for Rare Disease Patients: Beijing & Shanghai Surprisingly Low in New City Ranking
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the…
Opinion / The Chinese Doctor-Patient Relationship in the Digital Era
I recently had the pleasure to moderate an event on the COVID-19 impact on the relationship between Doctor and…